These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21890536)

  • 1. Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study.
    Coeman M; van Durme Y; Bauters F; Deschepper E; Demedts I; Smeets P; Joos G; Brusselle G
    Ther Adv Respir Dis; 2011 Dec; 5(6):377-86. PubMed ID: 21890536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
    Wong C; Jayaram L; Karalus N; Eaton T; Tong C; Hockey H; Milne D; Fergusson W; Tuffery C; Sexton P; Storey L; Ashton T
    Lancet; 2012 Aug; 380(9842):660-7. PubMed ID: 22901887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
    Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
    J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab in patients with severe asthma: the XCLUSIVE study.
    Schumann C; Kropf C; Wibmer T; Rüdiger S; Stoiber KM; Thielen A; Rottbauer W; Kroegel C
    Clin Respir J; 2012 Oct; 6(4):215-27. PubMed ID: 21740532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL; Sammut PH; Judy CG; Colombo JL
    Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.
    Busse WW; Bleecker ER; Bateman ED; Lötvall J; Forth R; Davis AM; Jacques L; Haumann B; Woodcock A
    Thorax; 2012 Jan; 67(1):35-41. PubMed ID: 21828231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.
    Kerstjens HA; Disse B; Schröder-Babo W; Bantje TA; Gahlemann M; Sigmund R; Engel M; van Noord JA
    J Allergy Clin Immunol; 2011 Aug; 128(2):308-14. PubMed ID: 21636120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
    Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
    JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.
    Brusselle GG; Vanderstichele C; Jordens P; Deman R; Slabbynck H; Ringoet V; Verleden G; Demedts IK; Verhamme K; Delporte A; Demeyere B; Claeys G; Boelens J; Padalko E; Verschakelen J; Van Maele G; Deschepper E; Joos GF
    Thorax; 2013 Apr; 68(4):322-9. PubMed ID: 23291349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.
    Diego AD; Milara J; Martinez-Moragón E; Palop M; León M; Cortijo J
    Respirology; 2013 Oct; 18(7):1056-62. PubMed ID: 23714268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS
    Clin Respir J; 2008 Oct; 2(4):247-8. PubMed ID: 20298343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy.
    Zanini A; Aiello M; Adamo D; Cherubino F; Zampogna E; Sotgiu G; Chetta A; Spanevello A
    Respiration; 2015; 89(6):525-33. PubMed ID: 25924686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function.
    Bastardo CM; Sonnappa S; Stanojevic S; Navarro A; Lopez PM; Jaffe A; Bush A
    Thorax; 2009 Mar; 64(3):246-51. PubMed ID: 19052050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of high-dose salmeterol/fluticasone and moderate-dose salmeterol/fluticasone plus low-dose mometasone in patients with severe persistent asthma.
    Kurashima K; Kagiyama N; Takayanagi N; Sugita Y
    Respirology; 2011 Jul; 16(5):784-9. PubMed ID: 21382132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores.
    Quittner AL; O'Donnell AE; Salathe MA; Lewis SA; Li X; Montgomery AB; O'Riordan TG; Barker AF
    Thorax; 2015 Jan; 70(1):12-20. PubMed ID: 25323621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.